#United States #New York #Class Action #Levi & Korsinsky #Hims & Hers Health

Hims & Hers Health's Class Action Lawsuit Notification

In a significant development, Levi & Korsinsky, LLP has issued a critical notice to shareholders of Hims & Hers Health, Inc. (HIMS) regarding a class-action lawsuit associated with alleged securities fraud. This notice pertains to a defined class of investors adversely impacted during a specific period. The firm aims to assist these investors in recovering potential losses stemming from this incident.

Class Definition

The class action lawsuit is explicitly designed for investors who experienced financial setbacks due to alleged securities fraud that occurred between April 29, 2025, and June 23, 2025. This time frame is crucial for determining eligibility and facilitating the claims process through the legal system. Investors who wish to learn more or express their interest in the lawsuit are encouraged to reach out through the provided links on the firm’s website.

Case Details

The lawsuit alleges serious misconduct on the part of the Company and its representatives. The central claims highlight that Hims & Hers Health might have engaged in deceptive practices, notably the promotion and sale of substandard knockoff versions of popular medications. Specifically, it raises concerns about the selling of illegitimate products intended to replicate Wegovy®—a medication renowned for its effectiveness in weight management and other health-related issues.

This alleged fraudulent promotion purportedly compromised patient safety and posed considerable risks. Moreover, it suggests that due to these actions, there was a significant possibility of Hims & Hers Health’s collaboration with Novo Nordisk being terminated. Such actions fundamentally mislead investors regarding the Company's operational integrity and future prospects, impacting their investments and financial decision-making.

How to Participate

Affected shareholders are given an urgent call to action—if you were impacted in any way during the specified period, you have until August 25, 2025, to take necessary steps to become a lead plaintiff. While participating in the lawsuit as a lead plaintiff could strengthen a shareholder's position, it is important to note that sharing in any recovery does not require one to serve in this role.

Levi & Korsinsky has reassured potential participants that engaging with the class action is free of charge, meaning members may qualify for compensation without incurring any out-of-pocket expenses related to this action. This class action presents an opportunity for investors to hold the Company accountable and potentially reclaim losses that have arisen from this alleged fraud.

Levi & Korsinsky’s Credentials

Levi & Korsinsky has a proven track record over the past two decades, successfully securing hundreds of millions in settlements for defrauded shareholders. The firm is renowned for handling high-stakes cases and has consistently ranked among the top securities litigation firms in America. With an experienced team dedicated to advocacy for investors, they aim to provide robust representation in this critical legal matter.

Contact Information

Investors wishing to get involved or asking for more information can contact Joseph E. Levi, Esq. at Levi & Korsinsky. The contact details include:

• - Email: [email protected]
• - Phone: (212) 363-7500

Their office is located at:
33 Whitehall Street, 17th Floor
New York, NY 10004

In conclusion, the lawsuit against Hims & Hers Health serves as a reminder of the potential risks in the investment landscape and the importance of due diligence. Affected shareholders should act swiftly to ensure their voices are heard and their interests protected as this case progresses. An opportunity to join forces with fellow shareholders could ultimately aid in reclaiming lost investments and uphold corporate accountability.